BXP to Record $18M Non-Cash Impairment Loss on $63M Property Sale
BXP sits 21% above its 52-week low of $49.72.
Summary
BXP, Inc. announced an agreement to sell a property for $63 million, which will result in an $18 million non-cash impairment loss in Q2 2026, reducing net income but not impacting FFO.
Key Events · Financing and Capital Events · BXP
-
Property Sale Agreement
A subsidiary of Boston Properties Limited Partnership entered into an agreement to sell a property in Washington, DC, for a gross purchase price of $63 million, receiving a $6 million non-refundable deposit.
-
Non-Cash Impairment Loss
The company expects to recognize a non-cash impairment loss of approximately $18 million in the second quarter of 2026, reducing net income by about $0.10 per diluted share/unit.
-
No FFO Impact
Crucially for a REIT, this impairment loss will have no impact on Funds from Operations (FFO), a key measure of operational performance.
-
Strategic Asset Sale
The property sale is consistent with the strategic asset sales plan outlined at BXP, Inc.'s September 2025 Investor Day.
Analysis · BXP · Real Estate & Construction
BXP, Inc. will recognize a non-cash impairment loss of $18 million in Q2 2026 due to the planned sale of a Washington, DC property for $63 million. While this reduces net income by $0.10 per diluted share, it is a non-cash charge and will not impact Funds from Operations (FFO), a key metric for REITs. The sale aligns with the company's previously announced strategic asset sales plan.
How filings like this one have moved
In the 30 days to Sep 22, 2026, 29.3% of the 1612 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BXP was trading at $60.01 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $9.6B. The 52-week trading range was $49.72 to $79.33. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.